Nasdaq or NYSE related Biotechnology: Biological Products (No Diagnostic Substances) industry Top Companies List by Market Cap as of January 2024

Nasdaq or NYSE listed Biotechnology: Biological Products (No Diagnostic Substances) industry Top Companies List by Market Cap as of Jan-05-2024. Nasdaq and NYSE related Biotechnology: Biological Products (No Diagnostic Substances) industry Largest Companies List by Market Cap as of Jan-05-2024

  1. Denali Therapeutics

    World Rank (Jan-05-2024)
    4,587
    Market Cap (Jan-05-2024)
    2.812 Billion USD
    World Rank (Jul-30-2023)
    3,643
    Market Cap (Jul-30-2023)
    3.830 Billion USD
    World Rank (Dec-25-2022)
    3,453
    Market Cap (Dec-25-2022)
    3.785 Billion USD
    World Rank (Jan-07-2022)
    3,242
    Market Cap (Jan-07-2022)
    5.08 Billion USD
    Annual Revenue in USD
    108 Million USD
    Annual Operating Income in USD
    -340 Million USD
    Annual Net Income in USD
    -325 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Denali Therapeutics is a Biotechnology company focused on Neurodegenerative Diseases. The headquarters is in USA.

    Company Website
    DENALI THERAPEUTICS INC

  2. Springworks Therapeutics

    World Rank (Jan-05-2024)
    4,628
    Market Cap (Jan-05-2024)
    2.777 Billion USD
    World Rank (Jul-30-2023)
    5,906
    Market Cap (Jul-30-2023)
    1.912 Billion USD
    World Rank (Dec-25-2022)
    6,680
    Market Cap (Dec-25-2022)
    1.453 Billion USD
    World Rank (Jan-07-2022)
    5,145
    Market Cap (Jan-07-2022)
    2.76 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -280 Million USD
    Annual Net Income in USD
    -277 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    SpringWorks Therapeutics is a clinical-stage targeted oncology company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from severe rare diseases and cancer. Headquarters is in Connecticut, USA.
    Company Website
    SPRINGWORKS THERAPEUTICS

  3. Beam Therapeutics Inc.

    World Rank (Jan-05-2024)
    5,482
    Market Cap (Jan-05-2024)
    2.121 Billion USD
    World Rank (Jul-30-2023)
    5,105
    Market Cap (Jul-30-2023)
    2.392 Billion USD
    World Rank (Dec-25-2022)
    4,254
    Market Cap (Dec-25-2022)
    2.844 Billion USD
    World Rank (Jan-07-2022)
    3,394
    Market Cap (Jan-07-2022)
    4.79 Billion USD
    Annual Revenue in USD
    61 Million USD
    Annual Operating Income in USD
    -338 Million USD
    Annual Net Income in USD
    -289 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Company Profile

    Beam Therapeutics is a Biotechnology company developing precision genetic medicines through the use of base editing. The headquarters is in USA.

    Facts About Company

    The company annual revenue is 60 million USD and net loss was -289 million USD as on Dec-2022.

    Company Website
    BEAM THERAPEUTICS INC.

  4. Iovance Biotherapeutics

    World Rank (Jan-05-2024)
    5,548
    Market Cap (Jan-05-2024)
    2.075 Billion USD
    World Rank (Jul-30-2023)
    6,175
    Market Cap (Jul-30-2023)
    1.782 Billion USD
    World Rank (Dec-25-2022)
    8,549
    Market Cap (Dec-25-2022)
    0.966 Billion USD
    World Rank (Jan-07-2022)
    5,413
    Market Cap (Jan-07-2022)
    2.55 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -398 Million USD
    Annual Net Income in USD
    -395 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Iovance Biotherapeutics is a development and commercialization of novel cancer immunotherapies based on tumor infiltrating lymphocytes company. The headquarters is in USA.
    Company Website
    IOVANCE BIOTHERAPEUTICS INC

  5. Twist Bioscience Corporation

    World Rank (Jan-05-2024)
    5,792
    Market Cap (Jan-05-2024)
    1.936 Billion USD
    World Rank (Jul-30-2023)
    7,096
    Market Cap (Jul-30-2023)
    1.428 Billion USD
    World Rank (Dec-25-2022)
    7,146
    Market Cap (Dec-25-2022)
    1.312 Billion USD
    World Rank (Jan-07-2022)
    4,437
    Market Cap (Jan-07-2022)
    3.39 Billion USD
    Annual Revenue in USD
    203 Million USD
    Annual Operating Income in USD
    -249 Million USD
    Annual Net Income in USD
    -217 Million USD
    Annual Results for Period Ending
    Sep-2022 ending year
    Headquarters Country
    USA
    Yahoo @ MunichGermany
    Company Profile
    TWIST BIOSCIENCE CORPORATION is Biotechnology company and has created silicon-based DNA synthesis platform, that offers precision at a scale otherwise unavailable to their customers.
    • Innovative silicon-based DNA Synthesis Platform enables production of high-quality synthetic DNA faster and more affordable than ever before
    • Platform technology overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis.

    Headquarters is in USA.

    Company Website
    TWIST BIOSCIENCE CORPORATION
    Wikipedia
    Wikipedia

  6. Prokidney Corp.

    World Rank (Jan-05-2024)
    6,039
    Market Cap (Jan-05-2024)
    1.812 Billion USD
    World Rank (Jul-30-2023)
    4,581
    Market Cap (Jul-30-2023)
    2.807 Billion USD
    World Rank (Dec-25-2022)
    5,906
    Market Cap (Dec-25-2022)
    1.755 Billion USD
    Headquarters Country
    USA
    Company Profile

    ProKidney is a late clinical-stage biotech company focused on the development of a pioneering cell therapy candidate that aims to transform the treatment landscape for Chronic Kidney Disease using a patient’s own cells.

    The headquarters is in USA.

    Company Website
    PROKIDNEY CORP.

  7. Vericel Corporation

    World Rank (Jan-05-2024)
    6,459
    Market Cap (Jan-05-2024)
    1.623 Billion USD
    World Rank (Jul-30-2023)
    6,143
    Market Cap (Jul-30-2023)
    1.797 Billion USD
    World Rank (Dec-25-2022)
    7,816
    Market Cap (Dec-25-2022)
    1.125 Billion USD
    World Rank (Jan-07-2022)
    6,909
    Market Cap (Jan-07-2022)
    1.71 Billion USD
    Annual Revenue in USD
    164 Million USD
    Annual Operating Income in USD
    -17 Million USD
    Annual Net Income in USD
    -17 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Bio pharmaceutical company with headquarters is in USA.
    Company Website
    VERICEL

  8. Relay Therapeutics Inc.

    World Rank (Jan-05-2024)
    6,953
    Market Cap (Jan-05-2024)
    1.434 Billion USD
    World Rank (Jul-30-2023)
    6,911
    Market Cap (Jul-30-2023)
    1.487 Billion USD
    World Rank (Dec-25-2022)
    5,890
    Market Cap (Dec-25-2022)
    1.765 Billion USD
    World Rank (Jan-07-2022)
    4,967
    Market Cap (Jan-07-2022)
    2.90 Billion USD
    Annual Revenue in USD
    1 Million USD
    Annual Operating Income in USD
    -310 Million USD
    Annual Net Income in USD
    -290 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Relay Therapeutics is a Biotechnology company related to Clinical Stage Precision Medicine company focused on transforming the drug discovery process. The company estimated annual revenue is currently 22 million per year and 122 employees as on 2019. The headquarters is in USA.
    Company Website
    RELAY THERAPEUTICS, INC.

  10. Vir Biotechnology

    World Rank (Jan-05-2024)
    7,125
    Market Cap (Jan-05-2024)
    1.382 Billion USD
    World Rank (Jul-30-2023)
    5,935
    Market Cap (Jul-30-2023)
    1.894 Billion USD
    World Rank (Dec-25-2022)
    3,703
    Market Cap (Dec-25-2022)
    3.425 Billion USD
    World Rank (Jan-07-2022)
    3,617
    Market Cap (Jan-07-2022)
    4.40 Billion USD
    Annual Revenue in USD
    1,580 Million USD
    Annual Operating Income in USD
    833 Million USD
    Annual Net Income in USD
    515 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Vir Biotechnology is a Clinical Stage Immunology company. It is focused on combining immunologic insights with cutting edge technologies to treat and prevent serious infectious diseases. The headquarters is in USA.

    Company Website
    VIR BIOTECHNOLOGY

Share